ICU Medical Inc: Form 10-K for the period ended Dec 31, 2010
Filed with the SEC on Feb 18, 2011 and accepted by EDGAR at Feb 18, 2011, 11:57 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2010-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2010-01-01 to 2010-12-31 | $284.6m | us-gaap:Revenues |
| Cost of revenue | 12 months2010-01-01 to 2010-12-31 | $154.0m | us-gaap:CostOfGoodsSold |
| Gross profit | 12 months2010-01-01 to 2010-12-31 | $130.6m | us-gaap:GrossProfit |
| Research and development | 12 months2010-01-01 to 2010-12-31 | $4.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2010-01-01 to 2010-12-31 | $76.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2010-01-01 to 2010-12-31 | $49.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2010-01-01 to 2010-12-31 | $18.5m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 12 months2010-01-01 to 2010-12-31 | $2.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2010-01-01 to 2010-12-31 | $2.27 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2010-01-01 to 2010-12-31 | 13,855,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2010-01-01 to 2010-12-31 | $33.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2010-01-01 to 2010-12-31 | $23.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2010-01-01 to 2010-12-31 | $28.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2010-12-31 | $78.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2010-12-31 | $207.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2010-12-31 | $312.2m | us-gaap:Assets |
| Current liabilities | At period end2010-12-31 | $25.8m | us-gaap:LiabilitiesCurrent |
Source: SEC EDGAR, the filing index for accession 0001104659-11-008318. Last ingested by Listed: Nov 14, 2026, 20:54 ET. Listed shows no prices and gives no investment advice.